Analyst Ratings for Sarepta Therapeutics (SRPT) [Neutrals]
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $224.00 (Wedbush)
- Lowest: $80.00 (Cantor Fitzgerald)
- Average: $156.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$156.60 (+26.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10 Percentile Rank: 80%
Rating Score: 7.5 / 10 Percentile Rank: 80%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/31/2023 | Oppenheimer | Hartaj Singh | Downgrade | Perform (Outperform) |
N/A (N/A) |
107.65 (123.97) |
15.16% | Details |
10/31/2023 | Cantor Fitzgerald » Updated 11/2/2023 |
Kristen Kluska | Downgrade | Neutral (Overweight) |
80.00 (40.00) |
106.83 (123.97) |
16.04% | Details |